Zobrazeno 1 - 10
of 309
pro vyhledávání: '"E. Tjønnfjord"'
Autor:
L. Garabet, A. Eriksson, E. Tjønnfjord, M. Kringstad Olsen, H. K. Jacobsen, C. Tøvik Jørgensen, Å.-B. Mathisen, M.-C. Mowinckel, M. T. Ahlen, I. Hausberg Sørvoll, K. Daae Horvei, S. Leiknes Ernstsen, I. Jenssen Lægreid, P. M. Sandset, W. Ghanima
Publikováno v:
HemaSphere, Vol 6, Pp 1565-1566 (2022)
Externí odkaz:
https://doaj.org/article/979a026707214dda941c89b138bf1e09
Autor:
Per Ole Iversen, Jean‐Louis Gueant, Abderrahim Oussalah, Helga Refsum, Ebba Nexo, Geir E. Tjønnfjord, Christian Qvigstad
Publikováno v:
Clinical Case Reports, Vol 12, Iss 11, Pp n/a-n/a (2024)
ABSTRACT Vitamin B12 deficiency is usually simple to diagnose. However, our patient demonstrates that in difficult cases, the ordinary clinician may need a transdisciplinary approach. The finding of a double haploinsufficiency as a possible cause of
Externí odkaz:
https://doaj.org/article/119d2ebc951f438783aae6a193714b17
Autor:
Ragnhild J. Måseide, MD, PhD, Erik Berntorp, MD, PhD, Jan Astermark, MD, PhD, Anna Olsson, MD, PhD, Maria Bruzelius, MD, PhD, Tony Frisk, MD, PhD, Vuokko Nummi, MD, PhD, Riitta Lassila, MD, PhD, Karin Strandberg, MD, PhD, Geir E. Tjønnfjord, MD, PhD, Pål A. Holme, MD, PhD
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 8, Pp 102611- (2024)
Background: The impact of nonneutralizing antibodies (NNAs) in moderate hemophilia is elusive. Objectives: To explore the presence of NNAs in Nordic persons with moderate hemophilia A (MHA) and B (MHB) in relation to treatment modality, clinical outc
Externí odkaz:
https://doaj.org/article/bb0e83a6d2b342da81ce3fe6d7b45074
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-7 (2024)
Abstract Background Natalizumab is a monoclonal antibody used to treat patients with relapsing–remitting multiple sclerosis. Anemia is a recognized side effect, but it is usually mild and of a short duration when natalizumab is stopped. Here, we de
Externí odkaz:
https://doaj.org/article/fc2cecd946034d73a262b7b311f3683b
Autor:
John F. Imbery, Celina Wiik, Julia Heinzelbecker, Jenny K. Jebsen, Mia K. Dobbing, Nunzio Bottini, Stephanie M. Stanford, Ludvig A. Munthe, Geir E. Tjønnfjord, Anders Tveita, Peter Szodoray, Britt Nakken
Publikováno v:
Molecular Therapy: Oncology, Vol 32, Iss 3, Pp 200841- (2024)
Chronic lymphocytic leukemia (CLL) growth is dependent on both B cell receptor (BCR) signaling and signals from microenvironmental T helper (Th) cells. We previously described a mechanism where Th cells enhance BCR signaling and proliferation through
Externí odkaz:
https://doaj.org/article/dccaffd146a34de9944a3fd659392210
Autor:
Christian Qvigstad, Lars Q. Sørensen, Geir E. Tjønnfjord, Pål André Holme, Ingrid Pabinger, Cedric Hermans, Roseline d’Oiron, Robert Klamroth, Johannes Oldenburg, Natascha Marquardt, Peter Staritz, Olga Katsarou, Uri Martinowitz, Aharon Lubetsky, Gili Kenet, Annarita Tagliaferri, Maria Elisa Mancuso, Roger Schutgens, Pål André HolmE, Jerzy Windyga, Irena Zupan, Victor Jimenez Yuste, Ramiro Nunez, Philippe de Moerloose, Erik Berntorp, Jan Astermark, Campbell Tait, Gerry Dolan
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 5, Pp 102514- (2024)
Background: People with hemophilia often experience pain and suffer from comorbidities related to their bleeding disorder. Consequently, unemployment due to disability is prevalent among people with hemophilia. Objectives: To explore associations bet
Externí odkaz:
https://doaj.org/article/bbbcde5173814e1f8d9095c20136a013
Autor:
Ina Kreyberg, MD, PhD, Elisabeth Schrumpf, MD, PhD, Carl Fredrik von Krogh, MD, Rune Lilleng, MD, Geir E. Tjønnfjord, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 41, Iss , Pp 33-36 (2023)
Externí odkaz:
https://doaj.org/article/ad1350d7f308460c992df7ad2539ef97
Autor:
Johanne U. Hermansen, Yanping Yin, Aleksandra Urban, Camilla V. Myklebust, Linda Karlsen, Katrine Melvold, Anders A. Tveita, Kjetil Taskén, Ludvig A. Munthe, Geir E. Tjønnfjord, Sigrid S. Skånland
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract The microenvironment of chronic lymphocytic leukemia (CLL) cells in lymph nodes, spleen, and bone marrow provides survival, proliferation, and drug resistance signals. Therapies need to be effective in these compartments, and pre-clinical mo
Externí odkaz:
https://doaj.org/article/c9d49e1d86744257bcc85e229f404a21
Autor:
Aleksandra Urban, Johanne Hermansen, Yanping Yin, Weikaixin Kong, Rebecca Teglgaard, Christian Brieghel, Sabina Kersting, Geir E. Tjønnfjord, Mark-David Levin, Hoa T. T. Tran, Mattias Mattsson, Juha Ranti, Gerrit-Jan Veldhuis, Caspar Da Cunha-Bang, Rogier Mous, Julie Dubois, Arnon Kater, Carsten Niemann, Tero Aittokallio, Sigrid Skånland
Publikováno v:
HemaSphere, Vol 7, p e92046ec (2023)
Externí odkaz:
https://doaj.org/article/69ae2e40c7fe4a2ca9baae0e3b9e3035
Autor:
Leonardo Miranda Santana, Deepak B. Thimiri Govinda Raj, Andrea Cremaschi, Mariaserena Giliberto, Alexandra Gade, Arnoldo Frigessi, Geir E. Tjønnfjord, Ludvig A. Munthe, Sigrid S. Skånland, Manuela Zucknick, Kjetil Taskén
Publikováno v:
HemaSphere, Vol 7, p e743599b (2023)
Externí odkaz:
https://doaj.org/article/fd7ad490e30e42b99eeb8b1340c8b413